Cargando…
Synergistic anti-cancer effects of silibinin-etoposide combination against human breast carcinoma MCF-7 and MDA-MB-231 cell lines
OBJECTIVE(S): Recently, there is a significant focus on combination chemotherapy for cancer using a cytotoxic drug and a phytochemical compound. We investigated the effect of silibinin on etoposide-induced apoptosis in MCF-7 and MDA-MB-231 breast carcinoma cell lines. MATERIALS AND METHODS: The cyto...
Autores principales: | Koushki, Mahdie, Khedri, Azam, Aberomand, Mohammad, Akbari Baghbani, Kourosh, Mohammadzadeh, Ghorban |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mashhad University of Medical Sciences
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8751753/ https://www.ncbi.nlm.nih.gov/pubmed/35083008 http://dx.doi.org/10.22038/ijbms.2021.56341.12575 |
Ejemplares similares
-
Metformin synergistically increases the anticancer effects of lapatinib through induction of apoptosis and modulation of Akt/AMPK pathway in SK-BR3 breast cancer cell line
por: Neamati, Davood, et al.
Publicado: (2021) -
Rutin Promotes Proliferation and Orchestrates Epithelial–Mesenchymal Transition and Angiogenesis in MCF-7 and MDA-MB-231 Breast Cancer Cells
por: Hajimehdipoor, Homa, et al.
Publicado: (2023) -
Proteomics Profiling of KAIMRC1 in Comparison to MDA-MB231 and MCF-7
por: Alghanem, Bandar, et al.
Publicado: (2020) -
Polyphenols Sensitization Potentiates Susceptibility of MCF-7 and MDA MB-231 Cells to Centchroman
por: Singh, Neetu, et al.
Publicado: (2012) -
Combination of Silibinin and Curcumin Reduced Leptin Receptor Expression in MCF-7 Human Breast Cancer Cell Line
por: Dalimi-Asl, Somaye, et al.
Publicado: (2020)